Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  13,082 results for ""Rifampin""

Your Filters

Subject : tuberculosis
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R 2 randomized controlled trial.

  • Authors : Gafar F; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; McGill International TB Centre, McGill University, Montreal, Quebec, Canada

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacokinetics ; Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/therapeutic use

  • Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jul; Vol. 64 (1), pp. 107197. Date of Electronic Publication: 2024 May 14.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.

  • Authors : Burman W; Public Health Institute at Denver Health and the Department of Medicine, University of Colorado, Denver, Colorado, United States of America.; Rucsineanu O

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects

  • Source: PLoS medicine [PLoS Med] 2024 Jul 25; Vol. 21 (7), pp. e1004438. Date of Electronic Publication: 2024 Jul 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Twice-Daily Dolutegravir-Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention.

  • Authors : Podany AT; College of Pharmacy, University of Nebraska Medical Center, Omaha.; Cramer Y

Subjects: Pyridones* ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/administration & dosage ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/pharmacokinetics

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 15; Vol. 79 (4), pp. 983-989.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy.

  • Authors : Pi J; Research Center of Nano Technology and Application Engineering, The First Dongguan Affiliated Hospital, Dongguan Innovation Institute, Guangdong Medical University, China; Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan, Guangdong, China. Electronic address: .

Subjects: Graphite*/Graphite*/Graphite*/chemistry ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/immunology

  • Source: Pharmacological research [Pharmacol Res] 2024 Oct; Vol. 208, pp. 107379. Date of Electronic Publication: 2024 Aug 30.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8907422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Vigilance Needed in Treating a Child with Disseminated TB: A Case Report.

  • Authors : Velmurugan H; Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.; Neelambaram K

Subjects: Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/adverse effects ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/administration & dosage

  • Source: Infectious disorders drug targets [Infect Disord Drug Targets] 2025; Vol. 25 (1), pp. e190424229165.Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101269158 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin-based regimen: A retrospective observational case series.

  • Authors : Dou Y; Chest Hospital of Guangxi Zhuang Autonomous Region, Liuzhou, China.; Lu R

Subjects: Lamivudine*/Lamivudine*/Lamivudine*/therapeutic use ; Lamivudine*/Lamivudine*/Lamivudine*/administration & dosage ; Oxazines*/Oxazines*/Oxazines*/therapeutic use

  • Source: HIV medicine [HIV Med] 2024 Jun; Vol. 25 (6), pp. 754-758. Date of Electronic Publication: 2024 Mar 17.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1293

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.

  • Authors : Ngo HX; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA.; Xu AY

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacokinetics ; Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1680-1689.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection.

  • Authors : Phaisal W; Center for Medical Diagnostic Laboratories, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacokinetics ; Rifampin*/Rifampin*/Rifampin*/analogs & derivatives ; Rifampin*/Rifampin*/Rifampin*/administration & dosage

  • Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jun 03; Vol. 79 (6), pp. 1270-1278.Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

High-dose rifampicin to treat tuberculosis infection: potential and pitfalls.

  • Authors : Ryckman TS; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD 21230, USA. Electronic address: .; Salazar-Austin N

Subjects: Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy

  • Source: The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Jun; Vol. 12 (6), pp. 420-421. Date of Electronic Publication: 2024 Mar 26.Publisher: Elsevier Country of Publication: England NLM ID: 101605555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2619

Record details

Read More Add to Saved list
×
Academic Journal

Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial.

  • Authors : Namale PE; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. .; Department of Medicine, University of Cape Town, Cape Town, South Africa. .

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Rifampin*/Rifampin*/Rifampin*/administration & dosage ; HIV Infections*/HIV Infections*/HIV Infections*/complications

  • Source: Trials [Trials] 2024 May 08; Vol. 25 (1), pp. 311. Date of Electronic Publication: 2024 May 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

Read More Add to Saved list
×
  • 1-10 of  13,082 results for ""Rifampin""